| ■ 영문 제목 : Clinical Trial Biorepository & Archiving Solutions Market Size, Share & Trends Analysis Report By Service (Archiving Solution, Biorepository Services), By Product (Preclinical, Clinical), By Phase (II, III), And Segment Forecasts, 2023 - 2030
|
 | ■ 상품코드 : GRV23MR067
■ 조사/발행회사 : Grand View Research
■ 발행일 : 2023년 2월
■ 페이지수 : 120
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (납기:3일)
■ 조사대상 지역 : 세계
■ 산업 분야 : 바이오
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1인 열람용) | USD5,950 ⇒환산￦8,032,500 | 견적의뢰/주문/질문 |
| Multi User (5인 열람용) | USD6,950 ⇒환산￦9,382,500 | 견적의뢰/주문/질문 |
| Global/corporate License (기업 열람용) | USD8,950 ⇒환산￦12,082,500 | 견적의뢰/구입/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 임상시험 바이오리포지토리 및 아카이브 솔루션 시장 규모가 2023년부터 2030년 사이에 CAGR 8.3% 증가하여, 2030년에는 70억 달러에 달할 것으로 전망하고 있습니다. 본 조사 자료는 세계의 임상시험 바이오리포지토리 및 아카이브 솔루션 시장을 조사대상으로 하여, 조사 방법 및 범위, 개요, 시장 변동/동향/범위, 서비스별 (바이오리포지토리 서비스, 아카이브 솔루션 서비스) 분석, 제품별 (전임상 제품, 임상 제품) 분석, 단계별 (단계Ⅰ, 단계Ⅱ, 단계Ⅲ, 단계Ⅳ) 분석, 지역별 (북미, 유럽, 아시아 태평양, 중남미, 중동 및 아프리카) 분석, 경쟁 현황 등의 항목을 수록하고 있습니다. 또한 본 리포트는 Medpace, ATCC, Cell&co BioServices, Azenta US, Inc., Thermo Fisher Scientific Inc. (Patheon), Precision Medicine Group, LLC., Labcorp Drug Development, Q2 Solutions, LabConnect, Charles River Laboratories 등의 기업 정보가 포함되어 있습니다.
・조사 방법 및 범위
・개요
・시장 변동/동향/범위
・세계의 임상시험 바이오리포지토리 및 아카이브 솔루션 시장 규모 : 서비스별
- 바이오리포지토리 서비스의 시장 규모
- 아카이브 솔루션 서비스의 시장 규모
・세계의 임상시험 바이오리포지토리 및 아카이브 솔루션 시장 규모 : 제품별
- 전임상 제품의 시장 규모
- 임상 제품의 시장 규모
・세계의 임상시험 바이오리포지토리 및 아카이브 솔루션 시장 규모 : 단계별
- 단계Ⅰ의 시장 규모
- 단계Ⅱ의 시장 규모
- 단계Ⅲ의 시장 규모
- 단계 IV의 시장 규모
・세계의 임상시험 바이오리포지토리 및 아카이브 솔루션 시장 규모 : 지역별
- 북미의 임상시험 바이오리포지토리 및 아카이브 솔루션 시장 규모
- 유럽의 임상시험 바이오리포지토리 및 아카이브 솔루션 시장 규모
- 아시아 태평양의 임상시험 바이오리포지토리 및 아카이브 솔루션 시장 규모
- 중남미의 임상시험 바이오리포지토리 및 아카이브 솔루션 시장 규모
- 중동과 아프리카의 임상시험 바이오리포지토리 및 아카이브 솔루션 시장 규모
・경쟁 현황 |
■ 보고서 개요Clinical Trial Biorepository & Archiving Solutions Market Growth & Trends
The global clinical trial biorepository & archiving solutions market size is expected to reach USD 7.0 billion by 2030, registering a CAGR of 8.3%, from 2023 to 2030, according to a new report by Grand View Research, Inc. This is mainly due to the increasing importance of biological sample management in clinical trials and the desire to streamline data collection and reporting. In addition, the expansion of precision, personalized, and genomic medicine, increased R&D spending and efforts to make data gathering & reporting easier by employing software like the Laboratory Information Management System (LIMS) to manage laboratory samples are all key factors driving the industry growth.
Multiple regulatory agencies advise and develop best practices in biorepository operations. The International Society for Biological and Environmental Repositories has strengthened its position in the standardization of bio-storage procedures on a global level. The College of American Pathologists established the first biorepository accreditation scheme that adheres to stringent regulations to standardize biorepository practices. Biorepository standards for competence, impartiality, and consistent operation for bio storage have been issued by the International Organization for Standardization (ISO-20387).
The U.S. FDA has established Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), GDP, and Good Tissue Practice (GTP), which contain the elements associated with the packing and storage of drug products. In addition, the COVID-19 pandemic has created several growth opportunities for local companies. To enhance their foothold in the industry, key companies are adopting various plans and policies to gain a more significant revenue share in the global market. The important step key players can incorporate partnering with relevant third-party vendors. It can be achieved through proper communication and adjustments in the frequency and volume of clinical trial biorepository and archiving solutions.
Clinical Trial Biorepository & Archiving Solutions Market Report Highlights
• The biorepository services segment dominated the industry in 2022 due to the rise in R&D of advanced therapies, such as personalized medicine, and the requirement of high-quality biorepository practices for the collection, processing, testing, and storage of samples
• In terms of phase, the phase III segment dominated the industry in 2022 while the phase II segment is estimated to register the fastest CAGR from 2023 to 2030
• The clinical products segment held the largest share in 2022 as most clinical trial protocols depend largely on the analysis of biological specimens to meet the study endpoints
• Asia Pacific is anticipated to register the fastest growth rate over the forecast period. The shift of clinical trial sites from Western regions, such as Europe and North America, to Asia Pacific is a major factor driving the region
■ 보고서 목차Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Service
1.1.2 Phase
1.1.3 Product Type
1.1.4 Regional scope
1.1.5 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’S internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis (Model 1)
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective – 1
1.9.2 Objective – 2
1.9.3 Objective – 3
1.9.4 Objective – 4
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Clinical Trial Biorepository & Archiving Solutions Market: Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Growing number of pharmaceutical and biotechnology companies
3.3.1.2 Growing disease variation and prevalence
3.3.1.3 Increasing R&D investments
3.3.1.4 Growth in the CRO market
3.3.2 Market Restraint Analysis
3.3.2.1 Regulations in new drug development
3.3.2.2 Rising cost of clinical trials
3.4 Clinical Trial Biorepository & Archiving Solutions Market Analysis Tools
3.4.1 Porter’s Five Forces analysis
3.4.2 PESTEL analysis
3.5 Major Deals & Strategic Alliances
3.6 Covid-19 Impact
Chapter 4 Clinical Trial Biorepository & Archiving Solutions Market: Service Segment Analysis
4.1 Definitions & Scope
4.2 Clinical Trial Biorepository & Archiving Solutions: Market Share Analysis, 2022 & 2030
4.3 Biorepository Services
4.3.1 Biorepository services market, 2018 – 2030 (USD Million)
4.3.2 Warehousing & storage
4.3.2.1 Warehousing & storage market, 2018 – 2030 (USD Million)
4.3.3 Transportation
4.3.3.1 Transportation market, 2018 – 2030 (USD Million)
4.3.4 Sample Processing
4.3.4.1 Sample Processing market, 2018 – 2030 (USD Million)
4.3.5 Others
4.3.5.1 Others market, 2018 – 2030 (USD Million)
4.4 Archiving Solution Services
4.4.1 Archiving Solution Services market, 2018 – 2030 (USD Million)
4.4.2 Database Indexing and Management
4.4.2.1 Database Indexing and Management market, 2018 – 2030 (USD Million)
4.4.3 Scanning & Destruction
4.4.3.1 Scanning & Destruction, 2018 – 2030 (USD Million)
Chapter 5 Clinical Trial Biorepository & Archiving Solutions Market: Product Type Segment Analysis
5.1 Definitions & Scope
5.2 Clinical Trial Biorepository & Archiving Solutions: Market Share Analysis, 2022 & 2030
5.3 Preclinical Products
5.3.1 Preclinical ProductsMarket, 2018 – 2030 (USD Million)
5.4 Clinical Products
5.4.1 Clinical Products market, 2018 – 2030 (USD Million)
5.4.2 Human Tissue
5.4.2.1 Human Tissue market, 2018 – 2030 (USD Million)
5.4.3 Organs
5.4.3.1 Organs market, 2018 – 2030 (USD Million)
5.4.4 Stem cells
5.4.4.1 Stem cells market, 2018 – 2030 (USD Million)
5.4.5 Other biospecimens
5.4.5.1 Other biospecimens market, 2018 – 2030 (USD Million)
Chapter 6 Clinical Trial Biorepository & Archiving Solutions Market: Phase Segment Analysis
6.1 Definitions & Scope
6.2 Clinical Trial Biorepository & Archiving Solutions: Market Share Analysis, 2022 & 2030
6.3 Phase I
6.2.1 Phase I Market, 2018 – 2030 (USD Million)
6.4 Phase II
6.3.1 Phase II market, 2018 – 2030 (USD Million)
6.5 Phase III
6.4.1 Phase III market, 2018 – 2030 (USD Million)
6.6 Phase IV
6.5.1 Phase IV market, 2018 – 2030 (USD Million)
Chapter 7 Clinical Trial Biorepository & Archiving Solutions Market: Regional Analysis
7.1 Clinical Trial Biorepository & Archiving Solutions: Market Share Analysis, 2022 & 2030
7.2 North America
7.2.1 North America clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Canada clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.3 Europe
7.3.1 Europe clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.3.2 U.K.
7.3.2.1 U.K. clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.3.3 Germany
7.3.3.1 Germany clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.3.4 France
7.3.4.1 France clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Italy clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Spain clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.3.7 Sweden
7.3.7.1 Sweden clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.3.8 Denmark
7.3.8.1 Denmark clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.3.9 Norway
7.3.9.1 Norway clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Japan clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.4.3 China
7.4.3.1 China clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.4.4 India
7.4.4.1 India clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.4.5 Australia
7.4.5.1 Australia clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.4.6 South Korea
7.4.6.1 South Korea clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.4.7 Thailand
7.4.7.1 Thailand clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.5 Latin America
7.5.1 Latin America clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.5.4 Argentina
7.5.4.1 Argentina clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.5.5 Colombia
7.5.5.1 Colombia clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.6 MEA
7.6.1 MEA clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.6.4 UAE
7.6.4.1 UAE clinical trial biorepository & archiving solutions market, 2018 – 2030 (USD Million)
7.6.5 Kuwait
Chapter 8 Competitive Landscape
8.1 Company Profiles
8.1.1 Medpace
8.1.1.1 Company overview
8.1.1.2 Financial performance
8.1.1.3 Service benchmarking
8.1.1.4 Strategic Initiatives
8.1.2 ATCC
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Service benchmarking
8.1.2.4 Strategic Initiatives
8.1.3 Cell&co BioServices
8.1.3.1 Company overview
8.1.3.2 Financial performance
8.1.3.3 Service benchmarking
8.1.3.4 Strategic Initiatives
8.1.4 Azenta US, Inc.
8.1.4.1 Company overview
8.1.4.2 Financial performance
8.1.4.3 Service benchmarking
8.1.4.4 Strategic Initiatives
8.1.5 Thermo Fisher Scientific Inc. (Patheon)
8.1.4.1 Company overview
8.1.4.2 Financial performance
8.1.4.3 Service benchmarking
8.1.4.4 Strategic Initiatives
8.1.6 Precision Medicine Group, LLC.
8.1.6.1 Company overview
8.1.6.2 Financial performance
8.1.6.3 Service benchmarking
8.1.6.4 Strategic Initiatives
8.1.7 Labcorp Drug Development
8.1.7.1 Company overview
8.1.7.2 Financial performance
8.1.7.3 Service benchmarking
8.1.7.4 Strategic Initiatives
8.1.8 Q2 Solutions
8.1.8.1 Company overview
8.1.8.2 Financial performance
8.1.8.3 Service benchmarking
8.1.8.4 Strategic Initiatives
8.1.9 LabConnect
8.1.9.1 Company overview
8.1.9.2 Financial performance
8.1.9.3 Service benchmarking
8.1.9.4 Strategic Initiatives
8.1.10 Charles River Laboratories
8.1.10.1 Company overview
8.1.10.2 Financial performance
8.1.10.3 Service benchmarking
8.1.10.4 Strategic Initiatives
|
| ※본 조사보고서 [세계의 임상시험 바이오리포지토리 및 아카이브 솔루션 시장 (2023~2030) : 아카이브 솔루션, 바이오리포지토리 서비스] (코드 : GRV23MR067) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 임상시험 바이오리포지토리 및 아카이브 솔루션 시장 (2023~2030) : 아카이브 솔루션, 바이오리포지토리 서비스] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!
